Case Report: Concomitant Hereditary Spherocytosis and Protein C/Protein S Deficiency Presenting with Deep Vein Thrombosis

The human body relies on a delicate balance between two opposing forces: the ability to form clots to stop bleeding when injured, and the ability to keep blood flowing freely through veins and arteries. When this balance tips too far toward clotting, a condition known as thrombophilia, blood can form dangerous blockages inside vessels that should remain open. These blockages, called venous thromboembolisms, often appear as deep vein thrombosis in the legs or travel to the lungs as pulmonary embolisms. While some people develop these clots due to temporary factors like surgery or immobility, others carry inherited genetic traits that make their blood prone to clotting from the moment they are born. Two such rare genetic conditions involve the body's natural clot-busting system. In one, the body lacks sufficient amounts of Protein C, and in the other, it lacks Protein S. These proteins act as essential brakes on the clotting process; without them, the brakes fail, and the risk of a life-threatening clot rises significantly, often first appearing in teenagers or young adults.

Separately, there is a common inherited blood disorder called hereditary spherocytosis. In this condition, the red blood cells are not the usual flat, round discs but are instead shaped like small, rigid spheres. Because of this odd shape, the spleen, an organ that filters the blood, mistakenly identifies these cells as damaged and destroys them prematurely. This leads to a chronic shortage of red blood cells, known as anemia, and often causes jaundice and an enlarged spleen. For decades, medical understanding held that while hereditary spherocytosis caused anemia, it did not typically increase the risk of dangerous blood clots. The two conditions—clotting disorders and red blood cell shape defects—were generally studied as entirely separate problems.

A recent case report from Saidu Teaching Hospital in Pakistan brings these two distinct worlds together in a single, unexpected patient. The story centers on a teenage male who arrived at the hospital in acute distress, complaining of severe pain and swelling in his left leg. The leg was warm to the touch and tender, classic signs that a large blood clot had formed in the deep veins. The patient had no history of recent injury, surgery, or long periods of immobility that would typically trigger such an event, making the cause of his clotting a medical mystery. Initial blood tests confirmed the presence of a deep vein thrombosis, but the search for the underlying cause revealed a complex and rare combination of genetic factors.

When doctors examined the patient's blood under a microscope, they found a significant number of the spherical red blood cells characteristic of hereditary spherocytosis. This explained the patient's history of mild anemia and gallstones, which are common side effects of the body breaking down these fragile cells. However, the investigation did not stop there. A specialized panel of tests designed to look for clotting disorders revealed that the patient also had a severe deficiency in both Protein C and Protein S. These are the very "brakes" that prevent the blood from clotting too easily. The patient possessed a double genetic hit: his blood cells were the wrong shape, and his body lacked the natural mechanisms to stop clots from forming.

This finding was particularly striking because hereditary spherocytosis is not usually considered a risk factor for clotting. While the removal of the spleen in spherocytosis patients can sometimes increase clotting risk due to changes in blood cell counts, this patient had never undergone surgery. The researchers noted that the breakdown of the misshapen red blood cells might release substances that irritate the blood vessel walls, but the primary driver of the clot in this case appeared to be the combined lack of Protein C and Protein S. The patient's blood tests showed normal levels of other clotting factors and no signs of autoimmune diseases, confirming that the deficiencies were indeed inherited. The presence of the spherical cells was a crucial clue that led doctors to look deeper, uncovering the second, more dangerous condition.

The case highlights a critical lesson for medical practice: when a young person presents with a blood clot without an obvious cause, doctors must look for multiple hidden genetic risks rather than settling on a single explanation. In this instance, the coexistence of hereditary spherocytosis and the dual protein deficiencies created a perfect storm for thrombosis. The patient was treated with blood-thinning medication to dissolve the existing clot and prevent new ones from forming. The report concludes that while each of these conditions is rare on its own, their simultaneous occurrence, though extremely uncommon, is possible and dangerous. It serves as a reminder that the human body's systems are deeply interconnected, and a thorough examination of both blood cell shape and clotting proteins is essential to understand the full picture of a patient's health.